Recent Articles from Investor Brand Network

This article has been disseminated on behalf of Redwood AI Corp. and may include paid advertising.

This article has been disseminated on behalf of Cizzle Brands Corporation and may include paid advertising.

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

SKYX Platforms (NASDAQ: SKYX), a smart home and AI platform technology company, announced it will host a corporate update conference call on May 11, 2026, at 4:30 p.m. Eastern Time to discuss new developments, provide a first-quarter 2026 business overview and review financial results, with participation from Founder and Executive Chairman Rani Kohen, CEO Lenny Sokolow, President Steve Schmidt and CFO Marc Boisseau.

Lantern Pharma (NASDAQ: LTRN), an AI-driven precision oncology company, unveiled the next phase of development for its withZeta.ai platform, including planned launches of ZetaSwarm(TM), an autonomous multi-agent AI research system, ZetaOmics(TM), a computational biology and multi-omic analytics toolkit, and new enterprise-grade capabilities designed to support institutional oncology research and drug discovery workflows.

Rooftop solar panels are found in just 5% to 7% of American households due to high installation costs, building constraints, and landlord restrictions that keep the technology out of reach for many more. A smaller-scale alternative, known as plug-in or balcony solar, is drawing attention as a more accessible option .

Shares tied to crypto climbed on Monday, May 4, supported by renewed optimism around U.S. regulation and a strong move higher in Bitcoin prices.

The biotechnology sector is undergoing a meaningful shift in how companies are evaluated, challenging long-standing assumptions about value creation. Traditionally, valuation has been closely tied to revenue generation and near-term financial performance. However, this framework has never fully captured the realities of biotech, where long development timelines, regulatory complexity, and scientific uncertainty often delay commercialization for years.

Oragenics (NYSE American: OGEN) and Sigyn Therapeutics Inc. (OTCQB: SIGY) announced the signing of a letter of intent under which Oragenics expects to obtain an exclusive license to develop and commercialize Sigyn’s CardioDialysis(TM) blood purification technology for traumatic brain injury and chronic neurodegenerative diseases, complementing Oragenics’ Phase IIa intranasal neurosteroid candidate ONP-002 in a proposed dual-modality approach targeting inflammation on both sides of the blood-brain barrier.

Datavault AI (NASDAQ: DVLT) announced that management has begun evaluating a potential dividend spin-out of its Acoustic Sciences division into a standalone public company proposed to be named API Media, with the reserved Nasdaq ticker symbol “ADIO,” as the company seeks to separate its acoustic technologies and live events operations from its AI-driven data monetization business. The proposed transaction remains subject to board approval, definitive agreements, regulatory approvals and other closing conditions.

Nightfood Holdings (OTCQB: NGTF) announced its inclusion in an editorial published by AINewsWire examining the accelerating adoption of service robotics across industries including healthcare, logistics and hospitality, highlighting the company’s focus on scalable AI-driven robotics systems and strategic collaborations as global demand for automation continues to expand.

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, announced a strategic initiative to explore ibogaine-based therapeutics for traumatic brain injury and related neuropsychiatric conditions, including the filing of a provisional U.S. patent application covering compositions and methods using ibogaine and related compounds to treat TBI, PTSD and associated disorders.

NextPlat (NASDAQ: NXPL, NXPLW) a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels, announced that it will release its financial results for the first quarter ended March 31, 2026, on May 14, 2026.

HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care solutions, announced a commercial agreement with Beverly Hills-based concierge medical practice Atelier Health, expanding the company’s launch footprint into Southern California and completing its initial targeted markets alongside New York metro, Dallas and South Florida as it advances commercialization of its cable-free 3D ECG technology for remote cardiac monitoring and preventive cardiology.

A recent study highlights how careful planning of wind farm locations across Europe can help preserve visually appealing landscapes without significantly raising electricity generation costs. While this finding is encouraging at a continental scale, challenges still arise at regional levels where the goals of renewable energy expansion and landscape conservation often overlap.

Used electric vehicle sales are climbing sharply as prices close in on those of comparable gas-powered models. In March, used EV sales were 27.7% higher than the same month a year prior and 53.9% above February’s total, according to the Cox Automotive EV Monitor . A key factor behind the supply surge is the volume of vehicles leased between late 2022 and the end of 2023. Most of those agreements run three years, and the cars are now flowing back onto dealer lots in large numbers.

Three American tech companies, xAI, Google and Microsoft, have agreed to have any new AI models they develop safety-tested by the Department of Commerce . The tests will be conducted before those models become publicly accessible.

GameStop has made a surprising move by offering $55.5 billion to acquire eBay, one of the world’s oldest and most well-known online marketplaces. The offer, which was not requested by eBay, has quickly drawn global attention and could reshape the future of both companies if it succeeds.

Perpetuals.com (NASDAQ: PDC), an AI-powered fintech company, announced the filing of a U.S. patent application for BayesShield AI, a system designed to identify in real time which AI model or human expert is best suited for a specific decision, with applications across industries including finance, cybersecurity, healthcare and legal analysis, as the company seeks to address reliability and risk-control challenges limiting enterprise adoption of agentic AI systems.

On a warm afternoon in March, a surveillance camera positioned in Arizona’s Coconino National Forest picked up what appeared to be a thin column of smoke. The alert did not come from a lookout tower or a passing hiker but from an AI system trained to scan landscapes for early signs of fire.

The media is awash with news that a cruise ship, called MV Hondius, has suffered an outbreak of hantavirus . Three fatalities have occurred, with one victim confirmed to have died from this infection. Many people are wondering what this infection is and what they can do to stay safe or what they can do in case they are infected. We provide an explainer of the basics you need to know about this virus.

Nightfood Holdings (OTCQB: NGTF), operating as TechForce Robotics, announced the launch of its Enterprise Automation Division, expanding beyond its Robotics-as-a-Service platform into enterprise-scale automation solutions including system design, engineering, integration and deployment, as the company advances a multi-division growth strategy focused on artificial intelligence, robotics and automation across industries including hospitality, healthcare, logistics and advanced manufacturing.

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

NRx Pharmaceuticals (NASDAQ: NRXP) announced that the U.S. Food and Drug Administration cleared the company to initiate a Phase 2/3 clinical trial evaluating NRX-101 in patients with treatment-resistant major depressive disorder and suicidality receiving active or sham transcranial magnetic stimulation, with the study to be conducted by subsidiary NRx Defense Systems and expected to enroll 240 participants across academic, HOPE Therapeutics and military treatment facility sites.

McEwen (NYSE: MUX) (TSX: MUX) reported first-quarter 2026 financial results and provided updates on development and exploration projects across Canada, the U.S., Mexico and Argentina, highlighting progress toward its goal of increasing annual production to 250,000-300,000 gold equivalent ounces (“GEOs”) by 2030, supported by strong gold prices, advancing mine development at Stock and Grey Fox in Ontario, resource growth at Tartan and Windfall, expansion initiatives at Gold Bar and El Gallo, and continued advancement of the Los Azules copper project through McEwen Copper.

This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising.

This article has been disseminated on behalf of Search Minerals Inc. and may include paid advertising.

NanoViricides, Inc. (NYSE American: NNVC) announced its participation in the D. Boral Capital Global Conference on May 7, 2026, at The Plaza Hotel in New York City, where Anil R. Diwan, Ph.D., president and executive chairman, will host one-on-one meetings with investors and interested parties from 9:45 a.m. to 2:45 p.m. ET.

Annovis Bio (NYSE: ANVS), a Phase 3 clinical-stage biotechnology company developing buntanetap for neurodegenerative diseases including Alzheimer’s disease and Parkinson’s disease, announced that President and CEO Maria Maccecchini, Ph.D., will present at Fierce Biotech Week 2026 in Boston on May 13, discussing the scientific basis for treating Alzheimer’s disease as a multi-protein disorder and highlighting Annovis’ approach of targeting multiple neurotoxic proteins simultaneously through its lead drug candidate, buntanetap, which is currently in a pivotal Phase 3 clinical trial.

Global energy systems are under increasing strain as industrial demand accelerates and reliable baseload power becomes more critical to economic stability. Frontieras North America is developing a breakthrough energy-processing technology known as FASForm(TM) that deconstructs coal and other solid hydrocarbons into multiple high-value fuels and industrial products, redefining the utility and economics of coal without burning it. By unlocking the hidden components of coal through a patented Solid Carbon Fractionation process, the company is focused on delivering abundant, affordable, available energy solutions, and a new generation of diverse industrial revenue streams, from a resource long dismissed as outdated.

This article has been disseminated on behalf of Energy Fuels Inc. and may include paid advertising.

Efforts to expand where hemp-derived THC beverages can be sold in Colorado stalled this week as lawmakers were unable to gather enough support to move the proposal forward.

Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform offering a quicker and easier path to homeownership, was featured in a recent article that discussed its strong Q4 2025 results, highlighted by 127% year-over-year revenue growth to $2.5 million and a 44% increase in mortgage originations to $84.7 million. The results were driven by the company’s expansion of its digital mortgage platform and improved efficiency metrics. Alongside faster processing times and higher conversion rates, reflecting growing leverage through AI-driven automation, Beeline increased average revenue per loan by 31% while reducing costs by 18%. The company also launched its blockchain-enabled platform, BeelineEquity, which empowers homeowners to access equity without refinancing. Having eliminated corporate debt and strengthened its balance sheet in 2025, management is focused on scaling its mortgage business, growing BeelineEquity, and expanding AI and SaaS capabilities in 2026.

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising.

Cardio Diagnostics Holdings (NASDAQ: CDIO) was featured in a recent article that discussed its positioning as cardiovascular disease remains one of the most serious and costly health challenges worldwide, driving an urgent need for earlier detection and more precise, personalized treatment strategies. “Cardio Diagnostics Holdings is focused on addressing this need by developing advanced solutions that leverage artificial intelligence (‘AI’) and multi-omic biomarkers to deliver actionable insights from a simple blood sample, enabling more informed and timely care cardiac care decisions,” the publication reads.

Tonix Pharmaceuticals (NASDAQ: TNXP) announced an agreement effective May 1, 2026, with a leading group purchasing organization providing coverage to approximately 35 million U.S. commercial lives, or about 20% of the commercial market, for TONMYA (cyclobenzaprine HCl sublingual tablets) under standard utilization management criteria. The company said the agreement marks a key step in expanding patient access to its FDA-approved, non-opioid fibromyalgia treatment, as it continues to pursue additional coverage across commercial and government channels, with existing Medicaid coverage in 38 states representing approximately 55 million lives.

Oncotelic Therapeutics (OTCQB: OTLC) announced the consummation of a strategic asset transfer agreement with Lunai Bioworks, Inc., granting worldwide rights to its nose-to-brain (N2B) delivery system IP within biodefense and Alzheimer’s disease fields in exchange for $12.5 million in Series B convertible preferred stock. The agreement establishes an initiative focused on CNS-targeted therapeutics while supporting the company’s strategy to monetize its portfolio and retain control of core assets.

FG Nexus (NASDAQ: FGNX, FGNXP) announced the formation of a special committee of independent directors to evaluate strategic alternatives aimed at enhancing long-term stockholder value, including a previously disclosed potential business combination with FG Communities, Inc. The proposed transaction, considered a related-party deal, would expand the company’s real-world asset platform into income-producing affordable housing, though discussions remain preliminary with no assurance of completion.

Olenox Industries (NASDAQ: OLOX) announced it will effect a 1-for-10 reverse stock split of its common stock effective May 8, 2026, at 12:01 a.m. Eastern time, with shares expected to begin trading on a split-adjusted basis the same day under the existing symbol. The move is intended to increase the company’s share price to meet Nasdaq’s $1.00 minimum bid requirement, reducing outstanding shares from approximately 10.2 million to about 1.2 million while maintaining stockholder ownership percentages, aside from rounding adjustments for fractional shares.

Gold started the week on a losing streak, shedding about 2% to trade at about $4,521 as tensions in the Gulf escalated and caused oil prices to climb. At the same time, the reserve currency appeal of the U.S. dollar increased and the USD index strengthened. This confluence of factors is weighing on gold and exerting drag on its potential to record price increases.

Massimo Group (NASDAQ: MAMO) announced the launch of pre-orders and initial dealer orders for its Sentinel 770 HVAC UTV, expanding its lineup of fully enclosed, climate-controlled utility terrain vehicles as part of its Sentinel series. Building on the Sentinel 570 HVAC, the new model targets a gap in the UTV market by offering factory-integrated heating and cooling at price points below $20,000, aimed at consumer and commercial users including fleet, agricultural and municipal buyers, with the company expecting the Sentinel line to generate approximately $10 million in revenue in 2026 based on current demand and delivery visibility.

Electric vehicles are becoming more common on roads around the world, but many drivers still wonder how well they perform in extreme weather. To better understand this, the American Automobile Association (AAA) recently tested how electric vehicles handle high temperatures. The results show that heat does affect performance, but not as much as some people might expect.

Researchers at Johns Hopkins may have found a new approach to group 3 medulloblastoma, a deadly and hard-to-treat pediatric brain cancer. Mouse experiments suggest that disrupting how tumor cells generate energy can slow the disease. The research was conducted at the Kimmel Cancer Center and published in Acta Neuropathologica Communications.

AINewsWire Editorial Coverage : Demand for service robotics is accelerating worldwide as organizations increasingly adopt automation to manage workforce shortages, rising operating expenses and efficiency challenges. According to the International Federation of Robotics, adoption continues to broaden across industries, with hundreds of thousands of systems deployed annually and continued growth anticipated in sectors such as healthcare, logistics and hospitality. Market projections further support this outlook, estimating expansion from approximately $31 billion in 2026 to more than $131 billion by 2034, reflecting sustained double-digit growth fueled by advances in AI and automation. Nightfood Holdings Inc. (OTC: NGTF) ( Profile ), dba as TechForce Robotics, is aligning itself within this evolving landscape by prioritizing real-world deployment, scalable systems and strategic collaborations that support global expansion in AI-driven robotics. The company is working to establish itself as a forward-looking participant in the AI, automated robotics sector, alongside industry leaders, including NVIDIA Corporation (NASDAQ: NVDA), Tesla Inc. (NASDAQ: TSLA), Amazon.com Inc. (NASDAQ: AMZN) and…

BioAdaptives (OTC: BDPT) announced the launch of MyndRenew(TM), a nighttime dietary supplement designed to support sleep quality and the brain’s overnight recovery processes, addressing what the company describes as a critical gap in cognitive health as more than one-third of U.S. adults report insufficient sleep. MyndRenew(TM) is part of the MyndSystem(TM) platform, which targets full 24-hour cognitive support, with formulations tailored to both daytime performance and nighttime recovery.

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising.

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising.

This article has been disseminated on behalf of Powermax Minerals Inc. and may include paid advertising.

Nightfood Holdings (OTCQB: NGTF) operating through TechForce Robotics, is aligning its strategy with accelerating global demand for service robotics as adoption expands across healthcare, logistics and hospitality, driven by labor shortages, rising costs and efficiency needs. Industry data from the International Federation of Robotics and market projections point to growth from approximately $31 billion in 2026 to more than $131 billion by 2034, with Nightfood focusing on real-world deployment, scalable systems and strategic collaborations alongside major industry players including NVIDIA Corporation (NASDAQ: NVDA), Tesla Inc. (NASDAQ: TSLA), Amazon.com Inc. (NASDAQ: AMZN) and Alphabet Inc. (NASDAQ: GOOGL).

VolitionRx Limited (NYSE American: VNRX) announced submission for peer review of a clinical manuscript demonstrating the high accuracy of its Nu.Q Vet Feline prototype assay in detecting lymphoma in cats, achieving 97% specificity and identifying 86% of cases, advancing development of a blood-based liquid biopsy test for feline cancer.

Datavault AI (NASDAQ: DVLT) announced the closing of its registered direct offering of approximately 109.1 million shares, generating gross proceeds of about $60 million, before expenses, under a definitive agreement with institutional investors.

MedWell Ai (OTCQB: MWAI) reported filing its quarterly report for the period ended March 31, 2026, highlighting significant revenue growth and improved financial performance, with total revenue of $618,676 for the quarter versus $281,318 in the prior year period and $1.69 million for the nine-month period versus $425,327. The company also reduced its net loss to $227,939 for the quarter from $814,192 and reaffirmed full-year revenue guidance of $2.3 million, while continuing to lower expenses and liabilities.

Solowin Holdings (NASDAQ: AXG) announced its subsidiary AX Coin Bahrain has signed a non-binding memorandum of understanding with Singapore Gulf Bank to collaborate on stablecoin infrastructure, cross-border payments and digital asset initiatives across Asia and the Middle East.

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.

While the Trump administration has taken a partial step toward rescheduling marijuana, the move has left many in the industry uncertain about what comes next.

Information Services Group (NASDAQ: III) will mark its 20th anniversary by ringing the closing bell on May 5, 2026, at the Nasdaq MarketSite in New York, highlighting its growth into an AI-centered technology research and advisory firm with approximately 1,500 professionals serving more than 900 clients globally.

SKYX Platforms (NASDAQ: SKYX) announced it will deploy its smart home and building technologies in the renovation and expansion of The Grand Hotel du Parc in La Bourboule, France, supplying thousands of lighting and safety units as part of a three-phase project with Group OTT.

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) announced new retail media agreements with brands including Under Armour, Santa Barbara Polo Club, Slazenger, Rollox and SwissBrand to advertise on its smart cart platform in Israel, further advancing monetization of its in-store media network and supporting continued growth of its Retail Media Division.

Forward Industries (NASDAQ: FWDI) announced a strategic investment in onchain reinsurance company OnRe as part of its $5 million Series A round, alongside plans to deploy up to $25 million into OnRe’s yield-bearing token ONyc on Solana, expanding its treasury strategy into tokenized real-world assets and diversified income streams.

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

OptimumBank Holdings (NYSE American: OPHC) announced that Timothy Terry has retired as Principal Executive Officer and as President and CEO of OptimumBank, with Chairman Moishe Gubin appointed as Chief Executive Officer and Principal Executive Officer of both the company and the bank, and Braden R. Smith named President of the bank, effective May 1, 2026.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

Surging gold prices in early 2026 significantly weakened non-investment demand for the metal, particularly in the jewelry sector. As gold prices climbed above $5,000 per ounce for the first time, many consumers reduced purchases of gold for personal and decorative use.

Xiaomi is laying the groundwork for a European push, having opened an EV research and design center in Munich last year. The facility, headed by former BMW executive Rudolf Dittrich, focuses on adapting Xiaomi’s vehicles to European safety standards, charging infrastructure, and consumer expectations. Germany is slated to be the company’s debut overseas market when international sales begin in 2027.

Immunotherapy has emerged as a key weapon in the fight against cancer. However, nearly 80% of patients either don’t respond to these treatments or they become unresponsive after initially responding to the immunotherapy. The scientific community has been grappling with how to improve response rates, and a new study uncovering how cancer cells reprogram our immune cells to support cancer growth could provide a key .

The United States Navy is accelerating its use of AI to detect and clear naval mines in the Strait of Hormuz, a key maritime corridor for global energy supplies, according to details from a newly issued contract.

Renewable energy posted a series of historic milestones in the United States in 2025 and into 2026. Solar and wind output hit record highs, and clean sources supplied more than a quarter of the country’s electricity for the first time. The gains came despite federal policies broadly favoring fossil fuels over clean energy.

Canada, home to the world’s first Bitcoin ATM, is now considering removing the machines altogether. The first of these devices debuted in April 2013 inside a small café in Vancouver, offering a simple way for people to exchange cash for Bitcoin without needing a bank account or financial intermediary. Over time, that concept spread quickly.

Makers of consumer electronics, such as laptops and smartphones, are facing chip shortages as chip demand within the AI data centers skyrockets. These shortages in the consumer electronics industry are happening even if the type of chips they require differs from those needed in data centers.

Investment banking played a key role in helping UBS report a strong rise in profits in the first quarter of 2026. The Swiss banking giant announced that its net profit reached $3 billion, marking an 80 percent increase compared to the same period last year. This result was much higher than what analysts had expected, showing that the bank started the year on a very solid note.

This article has been disseminated on behalf of McEwen Inc. and may include paid advertising.

NRx Pharmaceuticals (NASDAQ: NRXP) announced it has initiated its first commercial manufacturing order of preservative-free ketamine in anticipation of potential approval under the Generic Drug User Fee Act in summer 2026, supported by stability data from multiple registration batches and a successful third-party manufacturing audit.

Cardiovascular disease continues to be a major global health challenge, driven by aging populations, lifestyle factors and persistent gaps in early detection that continue to challenge healthcare systems. In response to these trends, HeartBeam (NASDAQ: BEAT) is developing technology aimed at improving how cardiac conditions are identified and monitored, positioning its solutions at the intersection of rising clinical need and evolving innovation.